Sponsors and exhibitors


Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious diseases. Our people are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. We have built a sustainable pipeline of potential therapies, and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient at the right time to achieve the best outcome. 

Through the Bristol-Myers Squibb Foundation, we promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions, giving new hope to some of the world’s most vulnerable people. Each day, our employees around the world work together for patients – it drives everything we do.

Incyte Corporation is a biopharmaceutical company focused on the discovery, development, and commercialization of novel medicines to meet serious unmet medical needs in cancer and other diseases. Incyte’s drug discovery activities were initiated in 2002 on the belief that investments in innovation create value. Incyte remains committed to the rigorous pursuit of R&D excellence to improve the lives of patients, make a difference in health care, and build sustainable value for its stakeholders.


The Company strives to discover and develop first-in-class and best-in-class medicine and is advancing a diverse portfolio of large and small molecules comprised of 18 development candidates against 14 different molecular targets.


Headquartered in Wilmington, Delaware, Incyte Corporation has offices in Switzerland, nine other European countries and Japan. For more information, visit www.incyte.com. Follow @Incyte on Twitter at https://twitter.com/Incyte.


For more than a century, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Today, MSD continues be at the forefront of research to deliver innovative health solutions and advance the prevention and treatment of diseases that threaten people and animals around the world.


Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.


Novartis Oncology is a global leader in improving outcomes for people living with cancer and other diseases. We seek to transform cancer care through distinctive scientific and clinical strategies focused on developing targeted, immuno-oncology and combination therapies to create more effective options for patients. The company offers a wide range of innovative therapies to help meet patient needs and our oncology pipeline is one of the strongest and most productive in the industry. For more information about how we are helping to revolutionize the treatment of cancer and other diseases, please visit www.novartisoncology.com.

“Pierre Fabre Laboratories is a French multinational, privately-owned pharmaceutical and dermo-cosmetic company present in 130 countries.

Oncology is one of our priorities, with programs focusing particularly on targeted therapies, biotherapies and immuno-oncology.

We work in therapeutic areas of high unmet medical need, including onco-hematology and dermato-oncology (particularly skin tumors/melanoma).

Thanks to our experience in both innovation and manufacturing, we are now recognized as one of the leading global names in oncology,

in dermatology and in dermo-cosmetics with our international brand leader “Eau Thermale Avène”.


For more information, please visit www.pierre-fabre.com”.

Sanofi Genzyme, the specialty care global business unit of Sanofi, focuses on oncology, immunology, multiple sclerosis, and rare diseases.  Our approach is shaped by our experience developing highly specialized treatments and forging close relationships with physician and patient communities. We are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world.  Since 2015, Sanofi and Regeneron have been in a global collaboration agreement dedicated to pursuing a broad, ambitious and long-term vision for immuno-oncology.


For more information visit:




Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.


LEO Pharma helps people achieve healthy skin. By offering care solutions to patients in more than 130 countries globally, LEO Pharma supports people in managing their skin conditions. Founded in 1908 and owned by the LEO Foundation, the healthcare company has devoted decades of research and development to delivering products and solutions to people with skin conditions. LEO Pharma is headquartered in Denmark and employs around 5.000 people worldwide. For more information visit www.leo-pharma.com



3Gen, Inc. manufactures the DermLite brand of skin imaging devices.

FotoFinder is setting the pace in skin imaging worldwide with leading technology “Made in Germany”.


The bodystudio ATBM is the world leading system for polarized and non-polarized Automated Total Body Mapping, which you can also use for Guided Photo Documentation in aesthetics. The camera FotoFinder medicam 1000 offers the sharpest images in video dermoscopy, trichoscopy, capillaroscopy and inflammoscopy. Her little sister leviacam stands for ultralight brilliance in the most compact camera.


A world innovation is the Moleanalyzer pro software that provides comprehensive support in the assessment of melanocytic and non-melanocytic lesions, allowing risk evaluation via computer scoring aided by Artificial Intelligence (AI).


Further innovations are PASIvision for psoriasis monitoring and computerized PASI assessment as well as Trichovision for trichoscopy, hair analysis and diagnostic support via the TrichoLAB service. Discover also eDermoscopy with the latest handyscope and the FotoFinder and TrichoLAB services for clinical studies. 

To improve patient’s Quality of Life developing and producing, from own original projects, innovative, effective and safe therapeutic systems for clinical practice.


This is our Mission.


At IGEA, we study the clinical application of physical stimuli to biological systems.


Our main areas of interest are:



IGEA therapies, to improve bone healing and joint preservation.



Electrochemotherapy, to treat cancers.


Cells electroporation associated with low doses of anticancer drugs for a safe eradication of tumors.


Electrochemotherapy is a minimally invasive treatment combining a low dose of a chemotherapy drug and an electrical pulse (electroporation) applied directly to the cancer cells using specific multiple needle or individual needle electrodes.


Cliniporator® e Cliniporator® VITAE are the most advanced electroporation technologies for the treatment of tumor nodules located to the skin, subcutaneous tissue, parenchyma and bone.

Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company. It provides high-quality, affordable medicines trusted by customers and patients in over 150 countries across the world. Sun Pharma's global presence is supported by 42 manufacturing facilities spread across 6 continents, R&D centers across the globe and a multi-cultural workforce comprising over 50 nationalities. In India, the company enjoys leadership across 11 different classes of doctors with 30 brands featuring amongst top 300 pharmaceutical brands in India. Its footprint across emerging markets covers over 100 markets and 6 markets in Western Europe. Its Global Consumer Healthcare business is ranked amongst Top 10 across 3 global markets. Its API business footprint is strengthened through 14 world class API manufacturing facilities across the globe. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising about 2,000 scientists and R&D investments of approximately 8% of annual revenues.

Wisepress.com, Europe’s leading conference bookseller, has a complete range of books and journals relevant to the themes of the meeting. Books can be purchased at the stand or, if you would rather not carry them, posted to you – Wisepress will deliver worldwide. In addition to attending 200 conferences per year, Wisepress has a comprehensive medical and scientific bookshop online with great offers.


SBC servicios básicos de congresos
Mont-Roig, 13 Atc 2a
08006 Barcelona
Tel. +34 933685538
Fax +34 933685829